Trump Signs Order for Psychedelic Research

0:00President Donald Trump signed an executive order Saturday morning to speed up research on psychedelics for treating mental health issues like depression, PTSD, and addiction with a big focus on veterans. The Department of Health and Human Services gets $50 million to study therapies including IBegaine, a substance from an African shrub that's already helping people abroad but stays illegal here. Trump was there with Health Secretary Robert F. Kennedy, Jr., Dr. Mehmet Oz, and podcaster Joe Rogan. Trump called it historic reform, pushing the FDA to fast-track psychedelics, marked his breakthrough drugs, and opening a right to try path for. Desperate Patients Kennedy highlighted how over 6,000 veterans die by suicide each year, way more than battlefield losses since 9-11 over 21 times, more. Even stressed these substances got banned under Nixon's 1970 controlled substances act to hit civil rights and anti-war folks, not because.

1:00They're dangerous. Leading spots like Johns Hopkins and Stanford show real promise in trials for lasting relief. This move partners HHS with forward-thinking states on funding and data, potentially unlocking FDA approval and game-changing care for millions who don't respond to current meds. Have a bay news today, powered by AI bringing you what matters.